Prix Shenzhen Neptunus Interlong Bio-technique Co Ltd (08329.HK)

Shenzhen Neptunus Interlong Bio-Technique Co. Ltd. engages in the research and development, production and sales of medicines, the purchase and sales of medicines, and healthcare food products. The company is headquartered in Shenzhen, Guangdong and currently employs 1,474 full-time employees. The company went IPO on 2005-09-12. The firm operates its businesses through two segments. The Manufacturing and Selling of Medicines and Medical Devices segment is mainly engaged in manufacturing, sales of medicines and medical devices. The Sales and Distribution of Medicines, Healthcare Products and Medical Devices segment is mainly engaged in sales and distribution of medicines, healthcare products and medical devices. The firm mainly operates its businesses in the domestic market.